# Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

> **NCT02658032** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 276 (estimated)

## Conditions studied

- Smoking Cessation
- Biofeedback

## Interventions

- **BEHAVIORAL:** personalized cessation care
- **BEHAVIORAL:** bio feedback
- **OTHER:** standard care

## Key facts

- **NCT ID:** NCT02658032
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2020-10
- **Final completion:** 2020-10
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2023-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02658032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02658032, "Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02658032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*